We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Therapeutically Targeting the Interconnected Biology of the Gut
Blog

We recently had the pleasure of interviewing Paul-Peter Tak, CEO of Kintai Therapeutics. Tak discusses how Kintai Therapeutics are exploiting the power of big data and machine learning to unravel the interconnected biology of the gut, and explains how the enteric signaling network can be therapeutically targeted.

Read More

Easing the "Informatics Bottleneck" Burden in Next-generation Sequencing
Blog

Technology Networks recently spoke with Rosengarten and Raymond Mercier, VP and GM, Molecular Biology, Thermo Fisher Scientific, to learn more about how the co-marketing agreement between Thermo Fisher Scientific and Genialis will help ease the burden of the "informatics bottleneck" for research scientists.

Read More

Analyzing Sperm DNA Damage To Diagnose Male Infertility
Blog

A recent collaborative study between Examen and the Lister Fertility Clinic in London used Examen’s COMET assay to measure sperm DNA damage in men with unexplained infertility. We spoke with Professor Sheena Lewis, CEO of Examen, to learn more about the study, the links between sperm DNA damage and infertility, and the value of adding this parameter to fertility testing.

Read More

Translational Research in Clinical Proteomics
Blog

In this article, Gary Kruppa, VP of Proteomics at Bruker Daltonics, explores how proteomic methods can help achieve the ultimate goal of preventing and improving the treatment of disease.

Read More

Building a Community to Change Biology for the Better
Blog

Biological complexity is not getting any easier to unravel but utilizing the power of computers could make us better at it.

Read More

Illuminating Cancer Cells To Help Guide Surgery
Blog

Surgery, when used as a cancer treatment, is a procedure in which a surgeon identifies and removes the cancerous tissue from a patient’s body. We recently spoke with Christopher Barys, CEO at On Target Laboratories to learn more about the novel cancer imaging agents they are currently developing, designed to help surgeons identify and resect cancerous lesions.

Read More

Fighting Neurodegeneration by Understanding Inflammation
Blog

Neurodegenerative diseases are one of the most pressing challenges of our time and teasing out the cellular mechanisms underpinning these diseases is a key goal for researchers in the field. We talked to Stéphane Martinez of CISBIO to discuss how researchers can access information on neurodegenerative mechanisms and how we are beginning to recognize the contribution of the immune system to neurodegeneration.

Read More

Method “Matches” Medicines to Their Unique Protein Receptors
Blog

A receptor (drug target) can shift from a single subunit to a multi-structure in the presence of a ligand (drug compound) – a process known as "oligomerization". Now, using photon excitation microscopy, researchers report that they can uncover the various protein receptor oligomers formed in the absence or presence of different drug candidates that bind to them.

Read More

A Conversation on the "Latest and Greatest" in Metabolomics
Blog

Aided by advances in high-throughput technologies, the metabolomics research field has gained significant traction. We spoke with Baljit Ubhi, Ph.D. from SCIEX, about the recent developments in metabolomics, addressing the increasing focus on the microbiome, how it impacts metabolic disease, and the future directions of research, including "precision nutrition".

Read More

Life Science Technology Megatrends Shaping Our Future
Blog

Megatrends are overarching trends, ones that seed and embrace multiple market and technology developments. These trends already exist in our world today but are going to be even more important in the years to come. Here we highlight three technology megatrends that could be highly significant to our future.

Read More